Micro-Mobility Market Expected to be Worth $255 Billion By 2027
Palm Beach, FL – September 17, 2021 – FinancialNewsMedia.com News Commentary – The micro-mobility market is witnessing continually rising revenues. The market growth majorly attributes to the wide uptake of these small, lightweight vehicles, including bicycles, e-bikes, electric scooters, electric skateboards, shared bicycles, and electric pedal-assisted bicycles. Rising electric vehicle infrastructure development activities as a […]
Helbiz Inc. Announces Partnership between Helbiz Media and FOX Networks Group to Broadcast Serie B Championship
Helbiz Media awards FOX with exclusive audiovisual rights to 3 seasons of the Serie B championship Partnership marks the first time the Serie B Championship will be broadcast in the North American market All games and highlights to be broadcast across the USA and the Caribbean Games will be streamed in English […]
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
FN Media Group Presents USA News Group News Commentary Vancouver, BC –September 17, 2021 – USA News Group – Using the same technology as their Covid-19 shot, scientists behind the University of Oxford and AstraZeneca PLC (NASDAQ:AZN) are getting closer to developing a therapeutic cancer vaccine, based on promising animal studies results. Based on […]
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D
Palm Beach, FL – September 17, 2021 – FinancialNewsMedia.com News Commentary – The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This industry includes establishments that produce drugs used in chemotherapy, radiation, and surgery for treating […]
BIOVAXYS CANCER VACCINE MANUFACTURING PARTNER BIO ELPIDA REACHES BIOPRODUCTION MILESTONE
Vancouver, BC – September 17, 2021 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys”), announced today that cancer vaccine manufacturing partner Bio Elpida in Lyon, France, has reached major milestones in the development of the bioproduction process for BVX-0918A, BioVaxys’ ovarian cancer vaccine and is beginning the next phase of manufacturing process development. Bio […]
